Patients with high-risk melanoma who received a personalized mRNA cancer vaccine alongside pembrolizumab after surgery saw ...

A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in ...

In recent days, Moderna and Merck reported five-year Phase 2b data showing that their personalized mRNA melanoma vaccine ...

Arcturus Therapeutics (NASDAQ:ARCT) President and CEO Joseph Payne outlined the company's messenger RNA programs, vaccine ...

A vaccine and a drug that harness the immune system to attack cancer cells, has cut the risk of skin cancer recurrence and ...

Study results released on Monday revealed that a personalized mRNA vaccine manufactured by Moderna and Merck has shown ...

The COVID-19 mRNA-based vaccines that saved 2.5 million lives globally during the pandemic could help spark the immune system to fight cancer. This is the surprising takeaway of a new study that we ...

Moderna’s mRNA flu vaccine gave more protection against illness than the standard flu shot in a phase 3 clinical trial, according to published results.

Messenger RNA vaccines aren’t just saving human lives—they are protecting elephants as well. In 2024, Tess, an elephant at the Houston Zoo, became the first to receive an mRNA vaccine developed by ...

Under the plans, CEPI has committed up to $50 million to US-based Moderna for preclinical development and Phase 1 clinical ...

Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid development of lifesaving covid shots. There's a catch: The mRNA technology ...